November 25, 2020 (v1)
Journal article
Therapeutical approaches providing effective medication for Alzheimer's disease (AD) patients after disease onset are urgently needed. Repurposing FDA approved drugs like fingolimod (FTY720) for treatment of AD is a promising way to reduce the time to bring such medication into clinical practice. Previous studies in AD mouse models suggested...
Uploaded on: December 4, 2022